Guru Ownership Trend
Guru Analysis for Royalty Pharma plc (RPRX)
Royalty Pharma plc (RPRX), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 6 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $305.79 M.
Top institutional holders include Cliff Asness and Pat Dorsey.
Notably, Pat Dorsey has expressed high conviction in this stock, allocating 7.59% of their equity portfolio to it.
Institutional sentiment is currently Bullish. This is evidenced by a $45.15 M net inflow during the quarter.
Recent activity highlights Steven Cohen who opened a new position. Conversely, Pat Dorsey reduced exposure by 3.9%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for Royalty Pharma plc (RPRX)
Major holders include Cliff Asness ($99.06 M), Pat Dorsey ($87.31 M), Paul Tudor Jones ($35.74 M). According to the latest reported data, 6 tracked investment managers collectively hold approximately 6.7 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $45.15 M, with 4 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 0 fully exited RPRX. The total reported sell value was $3.57 M.
Yes, 2 managers opened new positions in RPRX, and 2 increased their existing holdings. The total reported buy value was $48.72 M.